Testing effectiveness (Phase 2)Study completedNCT00033280
What this trial is testing
Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 42